The companies are also running an open-label study to evaluate the long-term efficacy and safety of the psychedelic in ...

FELIQS has concluded a $9m Series A funding round, a significant step towards advancing the FLQ-101 clinical programme for ROP.

Pfizer's recent trial termination makes it yet another company facing challenges with CD47 studies in oncology.

Javara has formed a collaboration with Cape Fear Valley Health to enhance clinical trial access for patients in Fayetteville, North Carolina.

OpRegen is a suspension of embryonic stem cell-derived RPE cells restoring visual function in degenerative retinal pathologies.